Medicare and Medicaid program; less than effective drugs and inpatient hospital tests--Health Care Financing Administration. Interim final rule with comment period.
This rule amends current Medicare and Medicaid regulations to implement two provisions of the Omnibus Budget Reconciliation Act of 1981 (Pub. L. 97-35). Those provisions are intended to assure that Federal funds are properly expended for drug products and inpatient tests without endangering the quality of care provided Medicare and Medicaid beneficiaries. The amendments pertain to the following subjects: I. Prohibition of the use of Federal funds under the Medicare Part B and Medicaid programs for drugs that the Food and Drug Administration of HHS has proposed, in a notice of opportunity for hearing, to withdraw from the market because they are less than effective. (Section 2103 of Pub. L. 97-35). II. Prohibition of the use of Federal funds under the Medicaid program for routine inpatient hospital tests unless they are ordered by the attending physician or other responsible practitioner for purposes of diagnosis and treatment of a patient's specific condition. This prohibition does not apply, however, for inpatient hospital tests furnished in emergency situations. (Section 2164 of Pub. L. 97-35).
D003955:Diagnostic Tests, Routine / Q000191:economics; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence; D008484:Medicaid / Q000331:legislation & jurisprudence*; D006278:Medicare / Q000331:legislation & jurisprudence*; D014481:United States